Evidence map›Paper›PMID 37737643›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2023

Mass Spectrometric Profiling of HLA-B44 Peptidomes Provides Evidence for Tapasin-Mediated Tryptophan Editing.

Amanpreet Kaur, Avrokin Surnilla, Anita J Zaitouna, Michael B Mumphrey, Venkatesha Basrur, Irina Grigorova, Marcin Cieslik, Mary Carrington, Alexey I Nesvizhskii, Malini Raghavan

Open access · greenAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Amanpreet KaurDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI.ORCID 0000-0001-6806-8448
Avrokin SurnillaDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI.
Anita J ZaitounaDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI.
Michael B MumphreyDepartment of Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor, MI.
Venkatesha BasrurDepartment of Pathology, University of Michigan Medical School, Ann Arbor, MI.ORCID 0000-0002-0853-9655
Irina GrigorovaDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI.ORCID 0000-0002-4963-7403
Marcin CieslikDepartment of Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor, MI.
Mary CarringtonBasic Science Program, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD.ORCID 0000-0002-2692-2180
Alexey I NesvizhskiiDepartment of Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor, MI.ORCID 0000-0002-2806-7819
Malini RaghavanDepartment of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI.ORCID 0000-0002-1345-9318
University of Michigan · USRagon Institute of MGH, MIT and Harvard · US

Funding

WORK ORDER 126643 B539 EXPAND IC SUITE75N91019D00024 · NIAID · LEIDOS BIOMEDICAL RESEARCH, INC. · PI BRISCOE, LYNN · 2019 to 2025
$3932.6M
University of Michigan Training Program in Genomic ScienceT32HG000040 · NHGRI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Sebastian Zoellner · 1995 to 2026
$16.4M
RESEARCH TRAINING IN EXPERIMENTAL IMMUNOPATHOLOGYT32AI007413 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Bethany B. Moore · 1993 to 2026
$9.8M
INTERACTIONS &MECHANISMS OF FUNCTION OF THE TAP COMPLEXR01AI044115 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MALINI RAGHAVAN · 1999 to 2026
$9.3M
Molecular Mechanisms of Microbial Pathogenesis Training ProgramT32AI007528 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CARRUTHERS, VERNON BRUCE · 1998 to 2024
$6.8M
COMPUTATIONAL TOOLS FOR MASS SPECTROMETRY-BASED INTERACTOME DATAR01GM094231 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Alexey I Nesvizhskii · 2010 to 2026
$5.4M
Michigan Center for Translational Cancer Proteogenomics-Diversity SupplementU24CA271037 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Saravana Mohan Dhanasekaran, Alexey I Nesvizhskii · 2022 to 2026
$4.4M
Proteogenomics of Cancer Training ProgramT32CA140044 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RAO, ARVIND, SARTOR, MAUREEN AGNES · 2010 to 2024
$3.9M
Peptide Repertoires of HLA class I moleculesR21AI126054 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RAGHAVAN, MALINI · 2017 to 2018
$428k
HLA class I peptidome diversities and CD8+ T cell responses to COVID-19 vaccinesR21AI164025 · NIAID · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI RAGHAVAN, MALINI · 2022 to 2023
$416k
NCI NIH HHS 75N91019D00024NCI NIH HHS T32 CA140044NCI NIH HHS U24 CA271037NHGRI NIH HHS T32 HG000040NIAID NIH HHS R01 AI044115NIAID NIH HHS R21 AI126054NIAID NIH HHS R21 AI164025NIAID NIH HHS T32 AI007413NIAID NIH HHS T32 AI007528NIGMS NIH HHS R01 GM094231
6 · The paper itself

Abstract

The extreme polymorphisms of HLA class I proteins result in structural variations in their peptide binding sites to achieve diversity in Ag presentation. External factors could independently constrict or alter HLA class I peptide repertoires. Such effects of the assembly factor tapasin were assessed for HLA-B*44:05 (Y116) and a close variant, HLA-B*44:02 (D116), which have low and high tapasin dependence, respectively, for their cell surface expression. Analyses of the HLA-B*44:05 peptidomes in the presence and absence of tapasin reveal that peptides with C-terminal tryptophans and higher predicted affinities are preferentially selected by tapasin, coincident with reduced frequencies of peptides with other C-terminal amino acids, including leucine. Comparisons of the HLA-B*44:05 and HLA-B*44:02 peptidomes indicate the expected structure-based alterations near the peptide C termini, but also C-terminal amino acid frequency and predicted affinity changes among the unique and shared peptide groups for B*44:02 and B*44:05. Overall, these findings indicate that the presence of tapasin and the tapasin dependence of assembly alter HLA class I peptide-binding preferences at the peptide C terminus. The particular C-terminal amino acid preferences that are altered by tapasin are expected to be determined by the intrinsic peptide-binding specificities of HLA class I allotypes. Additionally, the findings suggest that tapasin deficiency and reduced tapasin dependence expand the permissive affinities of HLA class I-bound peptides, consistent with prior findings that HLA class I allotypes with low tapasin dependence have increased breadth of CD8+ T cell epitope presentation and are more protective in HIV infections.

Indexed as

HIV InfectionsTryptophanHistocompatibility Antigens Class IHLA-B44 AntigenHLA-B AntigensHumansImmunoglobulinsMembrane Transport ProteinsPeptidesProtein BindingHistocompatibility Antigens Class IHLA-B44 AntigenHLA-B AntigensImmunoglobulinsMembrane Transport ProteinsPeptidestapasinTryptophan

Identifiers

PMID37737643
PMCPMC10592002
OpenAlexW4386944563

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.